Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy
Background Serotonin–norepinephrine reuptake inhibitors (SNRIs) inhibit the presynaptic reuptake of serotonin and norepinephrine and are widely used in the treatment of depression and neuropathic pain. We evaluate the impact of SNRIs use on the clinical outcomes of patients presenting with Takotsubo...
Saved in:
| Main Authors: | Garba Rimamskep Shamaki, Anderson Anuforo, Israel Safiriyu, David Corteville, Monika Sanghavi, Samit Shah, Katherine Clark |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.037951 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history
by: D. S. Danilov
Published: (2018-12-01) -
Chirality in Modern Antidepressants: A Comprehensive Review of Stereochemical Impacts on Pharmacology and Therapeutics
by: Gabriel Hancu, et al.
Published: (2024-09-01) -
Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories
by: Kerry L. Kinney, et al.
Published: (2025-06-01) -
Presumed insect sting–induced Takotsubo cardiomyopathy
by: Karl Maxemous, MD, et al.
Published: (2025-08-01) -
Selective Serotonin Reuptake Inhibitors and Risk of Gastrointesinal Bleeding In Dyspepsia: An Evidence-Based Case Report
by: Hamzah Shatri, et al.
Published: (2023-11-01)